Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Depreciation & Amortization (CF): 2018-2019

Historic Depreciation & Amortization (CF) for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $5,000.

  • DiaMedica Therapeutics' Depreciation & Amortization (CF) changed negligibly% to $5,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $21,000, marking a year-over-year increase of 40.00%. This contributed to the annual value of $39,000 for FY2024, which is 30.00% up from last year.
  • Per DiaMedica Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $5,000 for Q4 2019, which was down 0.00% from $5,000 recorded in Q3 2019.
  • DiaMedica Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $6,000 during Q1 2019, with a 5-year trough of $2,000 in Q2 2018.
  • For the 2-year period, DiaMedica Therapeutics' Depreciation & Amortization (CF) averaged around $4,500, with its median value being $5,000 (2019).
  • Data for DiaMedica Therapeutics' Depreciation & Amortization (CF) shows a peak YoY soared of 150.00% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows DiaMedica Therapeutics' Depreciation & Amortization (CF) stood at $5,000 in 2018, then remained steady at $5,000 in 2019.
  • Its last three reported values are $5,000 in Q4 2019, $5,000 for Q3 2019, and $5,000 during Q2 2019.